Valsartan in chronic heart failure [3] (multiple letters)

New England Journal of Medicine

Volumn 346, Issue 15, 2002, Pages 1173-1174

  Haddy, Francis J ^a   Campbell, Duncan John ^a   Cayley Jr , William E ^a   Forfar, J Colin ^a   Munir, Shahzad ^a   Cohn, Jay N ^a   Tognoni, Gianni ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALSARTAN; ANGIOTENSIN RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE; ANTIHYPERTENSIVE AGENT;

BRAIN BLOOD FLOW; ENZYME INHIBITION; HEART FAILURE; HUMAN; LETTER; PERFUSION PRESSURE; PRIORITY JOURNAL; RECEPTOR BLOCKING; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; MORTALITY; NOTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; CHEMICALLY INDUCED DISORDER; HYPOTENSION; RISK;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; VALINE; ANTIHYPERTENSIVE AGENTS; HYPOTENSION; RISK;

EID: 0037061910     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200204113461516     Document Type: Letter

References (0)